Different anti-aggregation and pro-degradative functions of the members of the mammalian sHSP family in neurological disorders

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1617, 2013, Pages 1-13

  Carra, Serena ^a,b   Rusmini, Paola ^c   Crippa, Valeria ^c   Giorgetti, Elisa ^c   Boncoraglio, Alessandra ^b,c   Cristofani, Riccardo ^c   Naujock, Maximillian ^b   Meister, Melanie ^b   Minoia, Melania ^b   Kampinga, Harm H ^b   Poletti, Angelo ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Chaperones; Heat shock proteins; Neurodegeneration; Small heat shock proteins

Indexed keywords

ACCUMULATION; APOPTOSIS; BIOCHEMICAL COMPOSITION; INHIBITION; MUSCLE; NEUROLOGY; PROTEIN; REDOX CONDITIONS;

MAMMALIA;

SMALL HEAT SHOCK PROTEIN;

ANIMAL; CENTRAL NERVOUS SYSTEM DISEASE; GENE EXPRESSION REGULATION; MAMMAL; METABOLISM; PHYSIOLOGY; PROTEOSTASIS DEFICIENCY; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; GENE EXPRESSION REGULATION; HEAT-SHOCK PROTEINS, SMALL; MAMMALS; PROTEOSTASIS DEFICIENCIES;

EID: 84883852928     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2011.0409     Document Type: Review

References (129)

1. Vos MJ, Zijlstra MP, Kanon B, van Waarde-Verhagen MA, Brunt ER, Oosterveld-Hut HM, Carra S, Sibon OC, Kampinga HH. 2010 HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones. Hum. Mol. Genet. 19, 4677-4693. (doi:10.1093/hmg/ddq398)
2. Kirbach BB, Golenhofen N. 2011 Differential expression and induction of small heat shock proteins in rat brain and cultured hippocampal neurons. J. Neurosci. Res. 89, 162-175. (doi:10. 1002/jnr.22536)
3. Quraishe S, Asuni A, Boelens WC, O'Connor V, Wyttenbach A. 2008 Expression of the small heat shock protein family in the mouse CNS: differential anatomical and biochemical compartmentalization. Neuroscience 153, 483-491. (doi:10.1016/j.neuro science.2008.01.058)
4. Boncoraglio A, Minoia M, Carra S. 2012 The family of mammalian small heat shock proteins (HSPBs): implications in protein deposit diseases and motor neuropathies. Int. J. Biochem. Cell Biol. 14, 1657-1669. (doi:10.1016/j.biocel.2012.03.011)
5. Franklin TB, Krueger-Naug AM, Clarke DB, Arrigo AP, Currie RW. 2005 The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system. Int. J. Hyperthermia 21, 379-392. (doi:10.1080/02656730500069955)
6. Kim DS, Lee SJ, Park SY, Yoo HJ, Kim SH, Kim KJ, Cho HJ. 2001 Differentially expressed genes in rat dorsal root ganglia following peripheral nerve injury. Neuroreport 12, 3401-3405. (doi:10.1097/ 00001756-200110290-00050)
7. Armstrong CL, Duffin CA, McFarland R, Vogel MW. 2011 Mechanisms of compartmental Purkinje cell death and survival in the Lurcher mutant mouse. Cerebellum 10, 504-514. (doi:10.1007/s12311-010-0231-4)
8. Sarna JR, Larouche M, Marzban H, Sillitoe RV, Rancourt DE, Hawkes R. 2003 Patterned Purkinje cell degeneration in mouse models of Niemann-Pick type C disease. J. Comp. Neurol. 456, 279-291. (doi:10.1002/cne.10522)
9. Brzyska M, Stege GJ, Renkawek K, Bosman GJ. 1998 Heat shock, but not the reactive state per se, induces increased expression of the small stress proteins HSP25 and a B-crystallin in glial cells in vitro. Neuroreport 9, 1549-1552. (doi:10.1097/ 00001756-199805110-00056)
10. Anagnostou G, Akbar MT, Paul P, Angelinetta C, Steiner TJ, de Belleroche J. 2010 Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord. Neurobiol. Aging 31, 969-985. (doi:10. 1016/j.neurobiolaging.2008.07.005)
11. Fukada Y, Yasui K, Kitayama M, Doi K, Nakano T, Watanabe Y, Nakashima K. 2007 Gene expression analysis of the Murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1. Brain Res. 1160, 1-10. (doi:10.1016/j. brainres.2007.05.044)
12. Maatkamp A, Vlug A, Haasdijk E, Troost D, French PJ, Jaarsma D. 2004 Decrease of Hsp25 protein expression precedes degeneration of motoneurons in ALS-SOD1 mice. Eur. J. Neurosci. 20, 14-28. (doi:10.1111/j.1460-9568.2004.03430)
13. Nakamoto H, Vigh L. 2007 The small heat shock proteins and their clients. Cell Mol. Life Sci. 64, 294-306. (doi:10.1007/s00018-006-6321-2)
14. Ninkina N, Peters O, Millership S, Salem H, van der Putten H, Buchman VL. 2009 g-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein. Hum. Mol. Genet. 18, 1779-1794. (doi:10.1093/hmg/ddp090)
15. Pieri I, Cifuentes-Diaz C, Oudinet JP, Blondet B, Rieger F, Gonin S, Arrigo AP, Thomas Y. 2001 Modulation of HSP25 expression during anterior horn motor neuron degeneration in the paralyse mouse mutant. J. Neurosci. Res. 65, 247-253. (doi:10.1002/jnr.1148)
16. Vleminckx V, Van Damme P, Goffin K, Delye H, Van Den Bosch L, Robberecht W. 2002 Upregulation of HSP27 in a transgenic model of ALS. J. Neuropathol. Exp. Neurol. 61, 968-974. (doi:10.1046/j.0179-1613.2003.00938.x)
17. Wilhelmus MM, Otte-Holler I, Wesseling P, de Waal RM, Boelens WC, Verbeek MM. 2006 Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains. Neuropathol. Appl. Neurobiol. 32, 119-130. (doi:10.1111/j.1365-2990.2006.00689.x)
18. Bryantsev AL, Kurchashova SY, Golyshev SA, Polyakov VY, Wunderink HF, Kanon B, Budagova KR, Kabakov AE, Kampinga HH. 2007 Regulation of stress-induced intracellular sorting and chaperone function of Hsp27 (HspB1) in mammalian cells. Biochem. J. 407, 407-417. (doi:10.1042/ BJ20070195)
19. Wyttenbach A, Sauvageot O, Carmichael J, Diaz-Latoud C, Arrigo AP, Rubinsztein DC. 2002 Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum. Mol. Genet. 11, 1137-1151. (doi:10.1093/hmg/11.9.1137)
20. An JJ et al. 2009 Transduced HSP27 protein protects neuronal cell death by enhancing FALS-associated SOD1 mutant activity. BMB Rep. 42, 136-141. (doi:10.5483/BMBRep.2009.42.3.136)
21. Carra S et al. 2013 Different anti-aggregation and pro-degradative functions of the members of the mammalian sHSP family in neurological disorders. Phil. Trans. R. Soc. B 368, 20110409. (doi:10.1098/ rstb.2011.0409)
22. Lavoie JN, Hickey E, Weber LA, Landry J. 1993 Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27. J. Biol. Chem. 268, 24210-24214. (doi:10.1890/08-1540.1)
23. Arrigo AP, Virot S, Chaufour S, Firdaus W, Kretz-Remy C, Diaz-Latoud C. 2005 Hsp27 consolidates intracellular redox homeostasis by upholding glutathione in its reduced form and by decreasing iron intracellular levels. Antioxid. Redox Signal. 7, 414-422. (doi:10.1089/ars.2005.7.414)
24. Suzuki A, Sugiyama Y, Hayashi Y, Nyu-i N, Yoshida M, Nonaka I, Ishiura S, Arahata K, Ohno S. 1998 MKBP, a novel member of the small heat shock protein family, binds and activates the myotonic dystrophy protein kinase. J. Cell Biol. 140, 1113-1124. (doi:10.1083/jcb.140.5.1113)
25. Sugiyama Y, Suzuki A, Kishikawa M, Akutsu R, Hirose T, Waye MM, Tsui SK, Yoshida S, Ohno S. 2000 Muscle develops a specific form of small heat shock protein complex composed of MKBP/HSPB2 and HSPB3 during myogenic differentiation. J. Biol. Chem. 275, 1095-1104. (doi:10.1074/jbc.275.2.1095)
26. Bhagyalaxmi SG, Srinivas P, Barton KA, Kumar KR, Vidyavathi M, Petrash JM, Bhanuprakash Reddy G, Padma T. 2009 A novel mutation (F71L) in aA-crystallin with defective chaperone-like function associated with age-related cataract. Biochim. Biophys. Acta 1792, 974-981. (doi:10.1016/j. bbadis.2009.06.011)
27. Kato S, Hirano A, Llena JF, Ito H, Yen SH. 1992 Ultrastructural identification of neurofibrillary tangles in the spinal cords in Guamanian amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam. Acta Neuropathol. 83, 277-282. (doi:10.1007/BF00296790)
28. Lowe J, Errington DR, Lennox G, Pike I, Spendlove I, Landon M, Mayer RJ. 1992 Ballooned neurons in several neurodegenerative diseases and stroke contain αB crystallin. Neuropathol. Appl. Neurobiol. 18, 341-350. (doi:10.1111/j.1365-2990.1992. tb00796.x)
29. Braak H, Del Tredici K, Sandmann-Kiel D, Rub U, Schultz C. 2001 Nerve cells expressing heat-shock proteins in Parkinson's disease. Acta Neuropathol. 102, 449-454.
30. Lowe J, Landon M, Pike I, Spendlove I, McDermott H, Mayer RJ. 1990 Dementia with beta-amyloid deposition: involvement of αB-crystallin supports two main diseases. Lancet 336, 515-516. (doi:10. 1016/0140-6736(90)92075-S)
31. Lowe J, McDermott H, Pike I, Spendlove I, Landon M, Mayer RJ. 1992 αB crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J. Pathol. 166, 61-68. (doi:10.1002/path.1711660110)
32. Sun Y, Makarava N, Lee CI, Laksanalamai P, Robb FT, Baskakov IV. 2008 Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size. J. Mol. Biol. 376, 1155-1167. (doi:10.1016/j.jmb.2007.12.053)
33. Renkawek K, Voorter CE, Bosman GJ, van Workum FP, de Jong WW. 1994 Expression of a B-crystallin in Alzheimer's disease. Acta Neuropathol. 87, 155-160. (doi:10.1007/BF00296185)
34. Shinohara H, Inaguma Y, Goto S, Inagaki T, Kato K. 1993 αB crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. J. Neurol. Sci. 119, 203-208. (doi:10.1016/0022-510X(93)90135-L)
35. Rekas A et al. 2004 Interaction of the molecular chaperone αB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity. J. Mol. Biol. 340, 1167-1183. (doi:10. 1016/j.jmb.2004.05.054)
36. Quinlan RA, Brenner M, Goldman JE, Messing A. 2007 GFAP and its role in Alexander disease. Exp. Cell Res. 313, 2077-2087. (doi:10.1016/j.yexcr. 2007.04.004)
37. Iwaki T, Iwaki A, Tateishi J, Goldman JE. 1994 Sense and antisense modification of glial a B-crystallin production results in alterations of stress fiber formation and thermoresistance. J. Cell Biol. 125, 1385-1393. (doi:10.1083/jcb.125.6.1385)
38. Nicholl ID, Quinlan RA. 1994 Chaperone activity of alpha-crystallins modulates intermediate filament assembly. EMBO J. 13, 945-953.
39. David JC, Boelens WC, Grongnet JF. 2006 Up-regulation of heat shock protein HSP 20 in the hippocampus as an early response to hypoxia of the newborn. J. Neurochem. 99, 570-581. (doi:10. 1111/j.1471-4159.2006.04071.x)
40. Edwards HV, Cameron RT, Baillie GS. 2011 The emerging role of HSP20 as a multifunctional protective agent. Cell Signal. 23, 1447-1454. (doi:10.1016/j.cellsig.2011.05.009)
41. Dreiza CM et al. 2005 Transducible heat shock protein 20 (HSP20) phosphopeptide alters cytoskeletal dynamics. FASEB J. 19, 261-263. (doi:10.1096/fj.04-2911fje)
42. Golenhofen N, Perng MD, Quinlan RA, Drenckhahn D. 2004 Comparison of the small heat shock proteins alphaB-crystallin, MKBP, HSP25, HSP20, and cvHSP in heart and skeletal muscle. Histochem. Cell Biol. 122, 415-425. (doi:10.1007/s00418-004-0711-z)
43. Crippa V et al. 2010 The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum. Mol. Genet. 19, 3440-3456. (doi:10.1093/hmg/ddq257)
44. Seidel K et al. 2011 The HSPB8-BAG3 chaperone complex is upregulated in astrocytes in the human brain affected by protein aggregation diseases. Neuropathol. Appl. Neurobiol. 38, 39-53. (doi:10. 1111/j.1365-2990.2011.01198.x)
45. Laskowska E, Matuszewska E, Kuczynska-Wisnik D. 2010 Small heat shock proteins and protein-misfolding diseases. Curr. Pharm. Biotechnol. 11, 146-157. (doi:10.2174/138920110790909669)
46. Carra S, Seguin SJ, Lambert H, Landry J. 2008 HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy. J. Biol. Chem. 283, 1437-1444. (doi:10.1074/jbc.M706304200)
47. Carra S, Sivilotti M, Chavez Zobel AT, Lambert H, Landry J. 2005 HspB8, a small heat shock protein mutated in human neuromuscular disorders, has in vivo chaperone activity in cultured cells. Hum. Mol. Genet. 14, 1659-1669. (doi:10.1093/hmg/ddi174)
48. Carra S, Brunsting JF, Lambert H, Landry J, Kampinga HH. 2009 HspB8 participates in protein quality control by a non-chaperone-like mechanism that requires eIF2a phosphorylation. J. Biol. Chem. 284, 5523-5532. (doi:10.1074/jbc.M807440200)
49. Lambert H, Charette SJ, Bernier AF, Guimond A, Landry J. 1999 HSP27 multimerization mediated by phosphorylation-sensitive intermolecular interactions at the amino terminus. J. Biol. Chem. 274, 9378-9385. (doi:10.1074/jbc.274.14.9378)
50. de Wit NJ, Verschuure P, Kappe G, King SM, de Jong WW, van Muijen GN, Boelens WC. 2004 Testis-specific human small heat shock protein HSPB9 is a cancer/testis antigen, and potentially interacts with the dynein subunit TCTEL1. Eur. J. Cell Biol. 83, 337-345. (doi:10.1078/0171-9335-00396)
51. Fontaine JM, Rest JS, Welsh MJ, Benndorf R. 2003 The sperm outer dense fiber protein is the 10th member of the superfamily of mammalian small stress proteins. Cell Stress Chaperones 8, 62-69. (doi:10.1379/1466-1268)
52. Kappe G, Franck E, Verschuure P, Boelens WC, Leunissen JA, de Jong WW. 2003 The human genome encodes 10 a-crystallin-related small heat shock proteins: HspB1-10. Cell Stress Chaperones 8, 53-61. (doi:10.1379/1466-1268)
53. Cobb BA, Petrash JM. 2000 Characterization of alpha-crystallin-plasma membrane binding. J. Biol. Chem. 275, 6664-6672. (doi:10.1074/jbc. 275.9.6664)
54. van Montfort RL, Basha E, Friedrich KL, Slingsby C, Vierling E. 2001 Crystal structure and assembly of a eukaryotic small heat shock protein. Nat. Struct. Biol. 8, 1025-1030. (doi:10.1038/nsb722)
55. Van Montfort R, Slingsby C, Vierling E. 2001 Structure and function of the small heat shock protein/alpha-crystallin family of molecular chaperones. Adv. Protein Chem. 59, 105-156. (doi:10.1016/S0065-3233(01)59004.X)
56. Ito H, Kamei K, Iwamoto I, Inaguma Y, Nohara D, Kato K. 2001 Phosphorylation-induced change of the oligomerization state of a B-crystallin. J. Biol. Chem. 276, 5346-5352. (doi:10.1074/jbc. M009004200)
57. Vos MJ, Zijlstra MP, Carra S, Sibon OC, Kampinga HH. 2011 Small heat shock proteins, protein degradation and protein aggregation diseases. Autophagy 7, 101-103. (doi:10.4161/auto. 7.1.13935)
58. Horwitz J. 1992 α-Crystallin can function as a molecular chaperone. Proc. Natl Acad. Sci. USA 89, 10449-10453. (doi:10.1073/pnas. 89.21.10449)
59. Leroux MR, Melki R, Gordon B, Batelier G, Candido EP. 1997 Structure-function studies on small heat shock protein oligomeric assembly and interaction with unfolded polypeptides. J. Biol. Chem. 272, 24646-24656. (doi:10.1074/jbc.272.39.24646)
60. Morrow G, Heikkila JJ, Tanguay RM. 2006 Differences in the chaperone-like activities of the four main small heat shock proteins of Drosophila melanogaster. Cell Stress Chaperones. 11, 51-60. (doi:10.1379/CSC-166.1)
61. Evgrafov OV et al. 2004 Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat. Genet. 36, 602-606. (doi:10.1038/ng1354)
62. Lavoie JN, Lambert H, Hickey E, Weber LA, Landry J. 1995 Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol. Cell. Biol. 15, 505-516.
63. Liang P, MacRae TH. 1997 Molecular chaperones and the cytoskeleton. J. Cell Sci. 110, 1431-1440.
64. Perng MD, Cairns L, van den IJssel P, Prescott A, Hutcheson AM, Quinlan RA. 1999 Intermediate filament interactions can be altered by HSP27 and alphaB-crystallin. J. Cell Sci. 112, 2099-2112.
65. Arrigo AP. 2001 Hsp27: novel regulator of intracellular redox state. IUBMB Life. 52, 303-307. (doi:10.1080/152165401317291165)
66. Paul C, Manero F, Gonin S, Kretz-Remy C, Virot S, Arrigo AP. 2002 Hsp27 as a negative regulator of cytochrome C release. Mol. Cell. Biol. 22, 816-834. (doi:10.1128/MCB.22.3.816-834.2002)
67. Paul C, Simon S, Gibert B, Virot S, Manero F, Arrigo AP. 2010 Dynamic processes that reflect anti-apoptotic strategies set up by HspB1 (Hsp27). Exp. Cell. Res. 316, 1535-1552. (doi:10.1016/j.yexcr. 2010.03.006)
68. Muchowski PJ, Wacker JL. 2005 Modulation of neurodegeneration by molecular chaperones. Nat. Rev. Neurosci. 6, 11-22. (doi:10.1038/nrn1587)
69. Sau D, Rusmini P, Crippa V, Onesto E, Bolzoni E, Ratti A, Poletti A. 2011 Dysregulation of axonal transport and motorneuron diseases. Biol. Cell 103, 87-107. (doi:10.1042/BC20100093)
70. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. 2004 Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810. (doi:10.1038/ nature02998)
71. Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, Clark HB, Zoghbi HY, Orr HT. 1998 Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95, 41-53. (doi:10.1016/S0092-8674(00)81781-X)
72. Simeoni S, Mancini MA, Stenoien DL, Marcelli M, Weigel NL, Zanisi M, Martini L, Poletti A. 2000 Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. Hum. Mol. Genet. 9, 133-144. (doi:10.1093/ hmg/9.1.133)
73. Rusmini P, Sau D, Crippa V, Palazzolo I, Simonini F, Onesto E, Martini L, Poletti A. 2007 Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy. Neurobiol. Aging 28, 1099-1111. (doi:10.1016/j.neurobiolaging.2006.05.015)
74. Saudou F, Finkbeiner S, Devys D, Greenberg ME. 1998 Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66. (doi:10.1016/S0092-8674(00)81782-1)
75. Tagawa K et al. 2004 Distinct aggregation and cell death patterns among different types of primary neurons induced by mutant huntingtin protein. J. Neurochem. 89, 974-987. (doi:10.1111/j.1471-4159.2004.02372.x)
76. Selkoe DJ. 2004 Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat. Cell Biol. 6, 1054-1061. (doi:10. 1038/ncb1104-1054)
77. Taylor JP, Tanaka F, Robitschek J, Sandoval CM, Taye A, Markovic-Plese S, Fischbeck KH. 2003 Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum. Mol. Genet. 12, 749-757. (doi:10. 1093/hmg/ddg074)
78. Adachi H et al. 2003 Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. J. Neurosci. 23, 2203-2211.
79. Bailey CK, Andriola IF, Kampinga HH, Merry DE. 2002 Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 11, 515-523. (doi:10.1093/hmg/11.5.515)
80. Chai Y, Koppenhafer SL, Bonini NM, Paulson HL. 1999 Analysis of the role of heat shock protein (HSP) molecular chaperones in polyglutamine disease. J. Neurosci. 19, 10338-10347.
81. Cummings CJ, Sun Y, Opal P, Antalffy B, Mestril R, Orr HT, Dillmann WH, Zoghbi HY. 2001 Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet. 10, 1511-1518. (doi:10.1093/hmg/10.14.1511)
82. Katsuno M, Sang C, Adachi H, Minamiyama M, Waza M, Tanaka F, Doyu M, Sobue G. 2005 Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc. Natl Acad. Sci. USA 102, 16801-16806. (doi:10.1073/pnas.0506249102)
83. Kobayashi Y, Sobue G. 2001 Protective effect of chaperones on polyglutamine diseases. Brain Res. Bull. 56, 165-168. (doi:10.1016/S0361-9230(01) 00593-7)
84. Koyama S et al. 2006 Alteration of familial ALS-linked mutant SOD1 solubility with disease progression: its modulation by the proteasome and Hsp70. Biochem. Biophys. Res. Commun. 343, 719-730. (doi:10.1016/j.bbrc.2006.02.170)
85. Patel YJ, Payne Smith MD, de Belleroche J, Latchman DS. 2005 Hsp27 and Hsp70 administered in combination have a potent protective effect against FALS-associated SOD1-mutant-induced cell death in mammalian neuronal cells. Brain Res. Mol. Brain Res. 134, 256-274. (doi:10.1016/j. molbrainres.2004.10.028)
86. Rusmini P, Simonini F, Crippa V, Bolzoni E, Onesto E, Cagnin M, Sau D, Ferri N, Poletti A. 2011 17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy. Neurobiol. Dis. 41, 83-95. (doi:10.1016/j.nbd. 2010.08.023)
87. Warrick JM, Chan HY, Gray-Board GL, Chai Y, Paulson HL, Bonini NM. 1999 Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet. 23, 425-428. (doi:10.1038/70532)
88. Waza M, Adachi H, Katsuno M, Minamiyama M, Sang C, Tanaka F, Inukai A, Doyu M, Sobue G. 2005 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat. Med. 11, 1088-1095. (doi:10.1038/nm1298)
89. Waza M, Adachi H, Katsuno M, Minamiyama M, Tanaka F, Doyu M, Sobue G. 2006 Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein. J. Mol. Med. 84, 635-646. (doi:10.1007/ s00109-006-0066-0)
90. Yamashita H, Kawamata J, Okawa K, Kanki R, Nakamizo T, Hatayama T, Yamanaka K, Takahashi R, Shimohama S. 2007 Heat-shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn superoxide dismutase: clues to a possible strategy for treating ALS. J. Neurochem. 102, 1497-1505. (doi:10.1111/j.1471-4159. 2007.04534.x)
91. Hageman J, Rujano MA, van Waarde MA, Kakkar V, Dirks RP, Govorukhina N, Oosterveld-Hut HM, Lubsen NH, Kampinga HH. 2010 A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation. Mol. Cell 37, 355-369. (doi:10.1016/j.molcel. 2010.01.001)
92. Vos MJ, Hageman J, Carra S, Kampinga HH. 2008 Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families. Biochemistry 47, 7001-7011. (doi:10.1021/bi800639z)
93. Dreiza CM, Komalavilas P, Furnish EJ, Flynn CR, Sheller MR, Smoke CC, Lopes LB, Brophy CM. 2010 The small heat shock protein, HSPB6, in muscle function and disease. Cell Stress Chaperones 15, 1-11. (doi:10.1007/s12192-009-0127-8)
94. Benn SC, Perrelet D, Kato AC, Scholz J, Decosterd I, Mannion RJ, Bakowska JC, Woolf CJ. 2002 Hsp27 upregulation and phosphorylation is required for injured sensory and motor neuron survival. Neuron 36, 45-56. (doi:10.1016/S0896-6273(02)00941-8)
95. Crippa V, Carra S, Rusmini P, Sau D, Bolzoni E, Bendotti C, De Biasi S, Poletti A. 2010 A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases. Autophagy 6, 958-960. (doi:10.4161/auto. 6.7.13042)
96. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. 2006 Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389-1392. (doi:10.1126/science. 1123511)
97. Trotti D, Rolfs A, Danbolt NC, Brown Jr RH, Hediger MA. 1999 SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat. Neurosci. 2, 427-433. (doi:10.1038/8091)
98. Onesto E, Rusmini P, Crippa V, Ferri N, Zito A, Galbiati M, Poletti A. 2011 Muscle cells and motoneurons differentially remove mutant SOD1 causing familial amyotrophic lateral sclerosis. J. Neurochem. 118, 266-280. (doi:10.1111/j.1471-4159.2011.07298.x)
99. Dobrowolny G et al. 2008 Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 8, 425-436. (doi:10.1016/j.cmet. 2008.09.002)
100. Wong M, Martin LJ. 2010 Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 19, 2284-2302. (doi:10.1093/hmg/ddq106)
101. Carra S et al. 2010 Identification of the Drosophila ortholog of HSPB8: implication of HSPB8 loss of function in protein folding diseases. J. Biol. Chem. 285, 37811-37822. (doi:10.1074/jbc. M110.127498)
102. Carra S. 2009 The stress-inducible HspB8-Bag3 complex induces the eIF2a kinase pathway: implications for protein quality control and viral factory degradation? Autophagy 5, 428-429. (doi:10.4161/auto.5.3.7894)
103. Klionsky DJ et al. 2008 Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4, 151-175.
104. Arndt V et al. 2010 Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr. Biol. 20, 143-148. (doi:10.1016/j.cub. 2009.11.022)
105. Kaganovich D, Kopito R, Frydman J. 2008 Misfolded proteins partition between two distinct quality control compartments. Nature 454, 1088-1095. (doi:10.1038/nature07195)
106. Carra S, Crippa V, Rusmini P, Boncoraglio A, Minoia M, Giorgetti E, Kampinga HH, Poletti A. 2012 Alteration of protein folding and degradation in motor neuron diseases: implications and protective functions of small heat shock proteins. Prog. Neurobiol. 97, 83-100. (doi:10.1016/j.pneurobio. 2011.09.009)
107. Fuchs M, Poirier DJ, Seguin SJ, Lambert H, Carra S, Charette SJ, Landry J. 2010 Identification of the key structural motifs involved in HspB8/HspB6-Bag3 interaction. Biochem. J. 425, 245-255. (doi:10. 1042/BJ20090907)
108. Qian J, Ren X, Wang X, Zhang P, Jones WK, Molkentin JD, Fan GC, Kranias EG. 2009 Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death. Circ. Res. 105, 1223-1231. (doi:10.1161/CIRCRESAHA.109.200378)
109. Filimonenko M et al. 2010 The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy. Mol. Cell 38, 265-279. (doi:10.1016/j.molcel. 2010.04.007)
110. Matsumoto G, Kim S, Morimoto RI. 2006 Huntingtin and mutant SOD1 form aggregate structures with distinct molecular properties in human cells. J. Biol. Chem. 281, 4477-4485. (doi:10.1074/jbc. M509201200)
111. Chen S, Ferrone FA, Wetzel R. 2002 Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl Acad. Sci. USA 99, 11884-11889. (doi:10.1073/pnas.182276099)
112. Ellisdon AM, Pearce MC, Bottomley SP. 2007 Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein. J. Mol. Biol. 368, 595-605. (doi:10.1016/j.jmb.2007.02.058)
113. Hardy J, Selkoe DJ. 2002 The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. (doi:10.1126/science.1072994)
114. Ignatova Z, Gierasch LM. 2006 Extended polyglutamine tracts cause aggregation and structural perturbation of an adjacent beta barrel protein. J. Biol. Chem. 281, 12959-12967. (doi:10.1074/jbc.M511523200)
115. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A, Saitoh T. 1995 The precursor protein of non-A b component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14, 467-475. (doi:10.1016/0896-6273(95)90302-X)
116. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L. 2000 Dopaminergic loss and inclusion body formation in a-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269. (doi:10.1126/science.287.5456.1265)
117. Scherzinger E et al. 1997 Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549-558. (doi:10.1016/S0092-8674(00)80514-0)
118. Ross CA, Poirier MA. 2004 Protein aggregation and neurodegenerative disease. Nat. Med. 10(Suppl.), S10-S17. (doi:10.1038/nm1066)
119. Waudby CA et al. 2010 The interaction of alphaB-crystallin with mature alpha-synuclein amyloid fibrils inhibits their elongation. Biophys. J. 98, 843-851. (doi:10.1016/j.bpj.2009. 10.056)
120. Rekas A, Jankova L, Thorn DC, Cappai R, Carver JA. 2007 Monitoring the prevention of amyloid fibril formation by alpha-crystallin. Temperature dependence and the nature of the aggregating species. FEBS J. 274, 6290-6304. (doi:10.1111/j. 1742-4658.2007.06144.x)
121. Robertson AL, Headey SJ, Saunders HM, Ecroyd H, Scanlon MJ, Carver JA, Bottomley SP. 2010 Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation. Proc. Natl Acad. Sci. USA 107, 10424-10429. (doi:10.1073/ pnas.0914773107)
122. Masino L, Nicastro G, Menon RP, Dal Piaz F, Calder L, Pastore A. 2004 Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3. J. Mol. Biol. 344, 1021-1035. (doi:10. 1016/j.jmb.2004.09.065)
123. Brooks P et al. 2000 Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem. J. 346, 155-161. (doi:10.1042/0264-6021:3460155)
124. Xie Z, Klionsky DJ. 2007. Autophagosome formation: core machinery and adaptations. Nat. Cell Biol. 9, 1102-1109. (doi:10.1038/ncb1007-1102)
125. Montie HL, Cho MS, Holder L, Liu Y, Tsvetkov AS, Finkbeiner S, Merry DE. 2009 Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 18, 1937-1950. (doi:10.1093/ hmg/ddp115)
126. Tsai HF, Lin SJ, Li C, Hsieh M. 2005 Decreased expression of Hsp27 and Hsp70 in transformed lymphoblastoid cells from patients with spinocerebellar ataxia type 7. Biochem. Biophys. Res. Comm. 334, 1279-1286. (doi:10.1016/j.bbrc.2005.06.207)
127. Hsieh M, Tsai HF, Chang WH. 2005 HSP27 and cell death in spinocerebellar ataxia type 3. Cerebellum 4, 31-36. (doi:10.1080/14734220410026248)
128. Friedman MJ, Li S, Li XJ. 2009. Activation of gene transcription by heat shock protein 27 may contribute to its neuronal protection. J. Biol. Chem. 284, 27944-27951. (doi:10.1074/jbc.M109.037937)
129. Zourlidou A et al. 2007. Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation. Hum. Mol. Genet. 16, 1078-1090. (doi:10.1093/hmg/ddm057)